Farum, Denmark

Jan Lindy Sorensen


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jan Lindy Sorensen: Innovator in Medicinal Chemistry

Introduction

Jan Lindy Sorensen is a notable inventor based in Farum, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on compounds that interact with the histamine H3 receptor. With a total of 4 patents to his name, Sorensen's research has the potential to impact various medical conditions.

Latest Patents

Sorensen's latest patents focus on novel compounds that interact with the histamine H3 receptor. These compounds are particularly useful in treating a variety of diseases or conditions where histamine H3 interactions are beneficial. The applications of these compounds extend to the treatment of diseases affecting the central nervous system, peripheral nervous system, cardiovascular system, pulmonary system, gastrointestinal system, and endocrinological system. The novel compounds feature a core consisting of a six-membered aromatic ring that contains at least one nitrogen atom and two carbon atoms, with the remaining positions in the ring occupied by either carbon or nitrogen atoms.

Career Highlights

Throughout his career, Jan Lindy Sorensen has worked with prominent companies in the pharmaceutical industry. Notable among these are High Point Pharmaceuticals, LLC and Novo Nordisk A/S. His work in these organizations has allowed him to develop and refine his innovative ideas in medicinal chemistry.

Collaborations

Some of his notable coworkers include Knud Erik Andersen and Ingrid Pettersson. Their collaboration has contributed to the advancement of research in the field.

Conclusion

Jan Lindy Sorensen's contributions to medicinal chemistry through his innovative patents highlight his role as a significant inventor in the field. His work on histamine H3 receptor compounds has the potential to lead to advancements in the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…